Paraneoplastic cerebellar degeneration: a rare presentation of Hodgkin's disease.
Krishnan
K
K
Department of Internal Medicine, University of Michigan Medical School, Ann Arbor 48109-0504.
Bockenstedt
P
P
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D002526:Cerebellar Diseases / Q000175:diagnosis / Q000209:etiology*; D003072:Cognition Disorders / Q000175:diagnosis / Q000209:etiology; D003606:Dacarbazine / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000008:administration & dosage; D004401:Dysarthria / Q000175:diagnosis / Q000209:etiology; D005260:Female; D006689:Hodgkin Disease / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007762:Labyrinthitis / Q000175:diagnosis; D008581:Meningitis / Q000175:diagnosis; D009410:Nerve Degeneration; D009759:Nystagmus, Pathologic / Q000175:diagnosis / Q000209:etiology; D010257:Paraneoplastic Syndromes / Q000175:diagnosis / Q000209:etiology*; D011788:Quality of Life; D012074:Remission Induction; D014747:Vinblastine; D014750:Vincristine / Q000008:administration & dosage
D001761:Bleomycin; D014750:Vincristine; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin